SEC Form 4 · accession 0001493152-26-041251
Syra Health Corp · SYRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Priya Prasad
Officer — COO and CFO · Director
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001922335
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Stock UnitsF1 | $0.00 | Aug 31, 2026 | A | 86,696 | A | — | Aug 31, 2036 | Class A Common Stock | 86,696 | 86,696 | D |
| Stock OptionsF2 | $0.92 | Aug 31, 2026 | A | 60,687 | A | — | Aug 31, 2036 | Class A Common Stock | 60,687 | 60,687 | D |
| Restricted Stock UnitsF3 | $0.00 | Aug 31, 2026 | A | 26,009 | A | — | — | Class A Common Stock | 26,009 | 26,009 | D |
Explanation of responses
- F120% of the Performance Stock Units vest each year after date of grant subject to the achievement of certain company financial metrics.
- F220% of the options vest on each of December 31, 2027, 2028, 2029, 2030 and 2031.
- F320% of the restricted stock units vest on each of December 31, 2027, 2028, 2029, 2030 and 2031